No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

JVIR, SIR Foundation Honor Best Research Published in 2019

Editor: What To Know

  • Haskal, a professor with the department of radiology and medical imaging at the University of Virginia Health System in Charlottesville, also recognized the authors of an additional 12 clinical and five laboratory papers for their contributions.
  • , was honored with the award for outstanding clinical research paper for “Clinical and Economic Benefits of Stent Grafts in Dysfunctional and Thrombosed Hemodialysis Access Graft Circuits in the REVISE Randomized Trial.
  • The Journal of Vascular and Interventional Radiology (JVIR)—the Society of Interventional Radiology's (SIR's) peer-reviewed scientific journal—announced the 2019 JVIR Editor's Best awards in the May issue of the journal, published online today.

The Journal of Vascular and Interventional Radiology (JVIR)—the Society of Interventional Radiology’s (SIR’s) peer-reviewed scientific journal—announced the 2019 JVIR Editor’s Best awards in the May issue of the journal, published online today. The annual awards, supported by SIR Foundation, were chosen by the editor after a comprehensive editorial board review of all papers submitted to JVIR during the prior year.

2019 JVIR EDITOR’S AWARD FOR OUTSTANDING CLINICAL STUDY

Belinda A. Mohr, Ph.D., was honored with the award for outstanding clinical research paper for “Clinical and Economic Benefits of Stent Grafts in Dysfunctional and Thrombosed Hemodialysis Access Graft Circuits in the REVISE Randomized Trial.”

In citing why this paper stood out, JVIR Editor-in-chief Ziv J Haskal, M.D., FSIR, said, “The analysis adds to the growing base of rigorous economic assessments of our interventional therapies. Hemodialysis costs billions of dollars in America. Our growing number of prospective controlled IR-led trials, such as in end-stage renal disease, allow this very type of essential research to help define the societal value of interventions for our patients.”

2019 JVIR EDITOR’S AWARD FOR OUTSTANDING LABORATORY INVESTIGATION

Yuchen Huo, MA, of the University of California San Diego, was honored with the award for outstanding laboratory investigation for “Stress Conditions Induced by Locoregional Therapies Stimulate Enrichment and Proliferation of Liver Cancer Stem Cells.”

“The downstream immunologic effects of thermal and transcatheter oncological treatments are being methodically fleshed out in the IR literature,” said Haskal. “One aspect is the under-recognized potential stimulatory effect of locoregional HCC treatments which might risk promulgating HCC stem cell proliferation, lessening overall cancer outcomes. This study described and quantified this very effect and defined a pathway for potentially suppressing it.”

Haskal, a professor with the department of radiology and medical imaging at the University of Virginia Health System in Charlottesville, also recognized the authors of an additional 12 clinical and five laboratory papers for their contributions. “In my decade as editor, this year marked a remarkably rich and diverse one for interventional radiologic research,” noted Haskal.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy